|Articles|November 1, 2017
Talking Pharma Reputation with Bioethics International
Author(s)Michelle Maskaly
Jennifer Miller talks about about pharma's reputation problem.
Advertisement
Pharm Exec Editor, Michelle Maskaly sat down with Jennifer Miller, the founder & board president of Bioethics International. In this brief video, Jennifer talks about pharma's reputation.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
2
FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010
3
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
4
Additive Manufacturing's Application in Pharma and Biotech
5